رجوع
59
نطاق اليوم
KWD 35.67
KWD 37.15
نطاق 52 أسبوعًا
KWD 35.37
KWD 61.25
حجم التداول
294,884
متوسط 50 يوم / 200 يوم
KWD 41.25
/
KWD 46.56
الإغلاق السابق
KWD 36.63
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 24.1 | 0.3 |
| P/B | 1.1 | 2.9 |
| ROE % | 4.7 | 3.7 |
| Net Margin % | 3.4 | 3.8 |
| Rev Growth 5Y % | 8.0 | 10.0 |
| D/E | 0.8 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 5.550
KWD 5.490 – KWD 5.618
|
1.5 B | 1 |
| FY2027 |
KWD 4.928
KWD 4.838 – KWD 5.087
|
1.4 B | 3 |
| FY2026 |
KWD 4.355
KWD 4.335 – KWD 4.375
|
1.4 B | 3 |
النقاط الرئيسية
Revenue grew 8.00% annually over 5 years — modest growth
Earnings declined -64.47% over the past year
ROE of 4.72% is below average
Generating 150.88M in free cash flow
Cash machine — converts 320.65% of earnings into free cash flow
Capital efficient — spends only 1.44% of revenue on capex
النمو
Revenue Growth (5Y)
8.00%
Revenue (1Y)5.18%
Earnings (1Y)-64.47%
FCF Growth (3Y)19.13%
الجودة
Return on Equity
4.72%
ROIC4.12%
Net Margin3.42%
Op. Margin7.46%
الأمان
Debt / Equity
0.81
Current Ratio2.14
Interest Coverage3.30
التقييم
P/E Ratio
24.06
P/B Ratio1.10
EV/EBITDA18.77
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.18% | Revenue Growth (3Y) | 5.09% |
| Earnings Growth (1Y) | -64.47% | Earnings Growth (3Y) | -14.56% |
| Revenue Growth (5Y) | 8.00% | Earnings Growth (5Y) | -6.87% |
| Profitability | |||
| Revenue (TTM) | 1.37B | Net Income (TTM) | 47.06M |
| ROE | 4.72% | ROA | 2.02% |
| Gross Margin | 54.59% | Operating Margin | 7.46% |
| Net Margin | 3.42% | Free Cash Flow (TTM) | 150.88M |
| ROIC | 4.12% | FCF Growth (3Y) | 19.13% |
| Safety | |||
| Debt / Equity | 0.81 | Current Ratio | 2.14 |
| Interest Coverage | 3.30 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 24.06 | P/B Ratio | 1.10 |
| P/S Ratio | 0.82 | PEG Ratio | -0.41 |
| EV/EBITDA | 18.77 | Dividend Yield | 0.02% |
| Market Cap | 1.13B | Enterprise Value | 1.93B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.31B | 1.24B | 1.05B | 1.01B |
| Net Income | 47.06M | 132.42M | 64.46M | -80.58M | 62.54M |
| EPS (Diluted) | 1.51 | 4.26 | 2.04 | -2.68 | 1.94 |
| Gross Profit | 750.48M | 733.03M | 676.25M | 571.25M | 568.04M |
| Operating Income | 102.62M | 200.33M | 120.60M | 70.05M | 109.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.33B | 2.31B | 2.30B | 2.30B | 1.77B |
| Total Liabilities | 1.29B | 1.34B | 1.47B | 1.55B | 980.58M |
| Shareholders' Equity | 1.03B | 962.68M | 834.22M | 745.55M | 785.44M |
| Total Debt | 834.94M | 905.78M | 991.25M | 1.05B | 684.66M |
| Cash & Equivalents | 40.82M | 24.46M | 24.30M | 28.94M | 20.85M |
| Current Assets | 672.86M | 640.01M | 615.65M | 581.23M | 460.12M |
| Current Liabilities | 315.04M | 278.13M | 310.73M | 296.55M | 196.65M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#237 of 1052
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026